# Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury

> **NCT04341038** · PHASE3 · UNKNOWN · sponsor: **Hospital Universitari de Bellvitge** · enrollment: 84 (estimated)

## Conditions studied

- COVID-19
- Lung Injury

## Interventions

- **DRUG:** Tacrolimus
- **DRUG:** Methylprednisolone

## Key facts

- **NCT ID:** NCT04341038
- **Lead sponsor:** Hospital Universitari de Bellvitge
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-01
- **Primary completion:** 2020-06-01
- **Final completion:** 2020-07-01
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2020-04-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04341038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04341038, "Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT04341038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*